How should you guide patients on GLP-1 therapy who are planning pregnancy? Dr Almandoz breaks down when to stop treatment, ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with ...

Are GLP-1 therapies truly safe for long-term cardiovascular health? Dr Pandey unpacks key gaps in current research, ...

Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...

A Central Illinois cardiologist breaks down the potential benefits of GLP-1 medications on heart health. It was one of the ...

Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food ...

As consumers who use GLP-1 drugs seek lean, protein-rich foods, the demand for ground turkey has been increasing.

Declining sugar consumption among people taking GLP-1 drugs to combat diabetes and obesity and the impact of President’s ...

Supergut is setting sights on bold retail expansion with the help of fresh capital and new executive leadership with a track ...

Gut health brand Supergut has secured new capital from Full Frame Growth Partners, and brought in former CEO of Vital Proteins as CEO.

In recent years, the landscape of diabetes and weight management has been significantly altered by the rise of glucagon-like peptide-1 (GLP-1) receptor agonists. These medications, initially developed ...

Analysis of Aspen Pharmacare's H1 2025 results. Revenue up, EBITDA strong, focus on GLP-1s & sterile manufacturing. Learn ...